Keywords :
Adenocarcinoma/drug therapy/radiotherapy/secondary/therapy; Administration, Oral; Antineoplastic Agents, Alkylating/administration & dosage/adverse effects; Bone Neoplasms/drug therapy/radiotherapy/secondary/therapy; Chemotherapy, Adjuvant/adverse effects; Combined Modality Therapy; Cyclophosphamide/administration & dosage/adverse effects; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms/drug therapy/pathology/radiotherapy/therapy; Radiodermatitis/chemically induced/etiology; Radiotherapy, Adjuvant/adverse effects
Abstract :
[en] Radiation recall dermatitis is an inflammatory skin reaction occurring in a previously irradiated field following the delivery of a promoting agent. It has been described after a number of antineoplastic agents such as gemcitabine, taxanes, anthracyclines. We report the case of a 50-year-old man with metastatic prostate cancer who developed two consecutive radiation recall dermatitis episodes triggered by oral cyclophosphamide. They occurred 4 to 5 weeks after palliative radiotherapy on bone metastasis. Spontaneous resolution was observed within 6 weeks after discontinuation of cyclophosphamide and with local supportive care. To our knowledge this is the first reported case of radiation recall dermatitis after oral cyclophosphamide.
Scopus citations®
without self-citations
5